title: Chronic hepatitis C of 28 years' duration characterized by early development of stage 2 (of 4) fibrosis but no significant progression over the subsequent 18 years.
authors.affiliation: Department of Medicine, Division of Digestive and Liver Diseases, Columbia University College of Physicians and Surgeons, New York, NY 10001, USA.
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Verna
authors.forename: Jay H
authors.initials: JH
authors.lastname: Lefkowitch
authors.forename: Paul D
authors.initials: PD
authors.lastname: Berk
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001706:Biopsy; D018450:Disease Progression; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008099:Liver / Q000473:pathology / Q000821:virology*; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D008297:Male; D017713:Platelet Transfusion / Q000009:adverse effects*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents